128 related articles for article (PubMed ID: 9636385)
1. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis.
Pham SM; Shears LL; Kawaharada N; Li S; Venkataramanan R; Sehgal S
Transplant Proc; 1998 Jun; 30(4):953-4. PubMed ID: 9636385
[No Abstract] [Full Text] [Related]
2. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Belitsky P; Gulanikar A; He G; Gupta R
Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
[No Abstract] [Full Text] [Related]
3. Protective effect of pyruvate during acute rejection of intestinal allografts: accompanied by up-regulation of inducible nitric oxide synthase mRNA.
Cicalese L; Hierholzer C; Subbotin V; Iyengar A; Rao AS; Stanko RT
Transplant Proc; 1997 May; 29(3):1813-4. PubMed ID: 9142283
[No Abstract] [Full Text] [Related]
4. Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model.
Cole OJ; Shehata M; Rigg KM
Transplant Proc; 1998 Aug; 30(5):2200-3. PubMed ID: 9723440
[No Abstract] [Full Text] [Related]
5. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
Chen H; Wu J; Luo H; Daloze P
Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
[No Abstract] [Full Text] [Related]
6. The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat.
Chen HF; Wu JP; Luo HY; Daloze PM
Transplant Proc; 1991 Aug; 23(4):2239-40. PubMed ID: 1714651
[No Abstract] [Full Text] [Related]
7. Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation.
Koskinen P; Kallio E; Tikkanen J; Bruggeman C; Häyry P; Lemström K
Transplant Proc; 1997; 29(1-2):798. PubMed ID: 9123530
[No Abstract] [Full Text] [Related]
8. Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis.
Lemström KB; Koskinen PK; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Transpl Int; 1994; 7 Suppl 1():S383-4. PubMed ID: 11271259
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide production after syngeneic and allogeneic small bowel transplantation.
Platz KP; Mueller AR; Heckert C; Häusler M; Guckelberger O; Lobeck H; Neuhaus P
Transplant Proc; 1998 Sep; 30(6):2662-4. PubMed ID: 9745538
[No Abstract] [Full Text] [Related]
10. Effect of cyclosporine and ischemia on experimental transplant arteriosclerosis.
Domínguez J; Kompatzki A; Schultz M
Transplant Proc; 2001; 33(7-8):3735-6. PubMed ID: 11750591
[No Abstract] [Full Text] [Related]
11. Peripheral nerve allotransplant immunosuppressed with FK 506: preliminary results.
Büttemeyer R; Jones NF; Rao UN
Transplant Proc; 1995 Apr; 27(2):1877-8. PubMed ID: 7536979
[No Abstract] [Full Text] [Related]
12. Mucosal reactivity of the intestinal allograft during acute rejection.
Tabasco-Minguillán J; Cicalese L; Weber K; Lee RG; Rakela J
Transplant Proc; 1996 Oct; 28(5):2576-7. PubMed ID: 8907960
[No Abstract] [Full Text] [Related]
13. Inhibition of complement reduces obliterative bronchiolitis.
Kallio E; Lemström K; Ryan U; Häyry P; Koskinen P
Transplant Proc; 1999; 31(1-2):188. PubMed ID: 10083071
[No Abstract] [Full Text] [Related]
14. The role of alloantigen-independent factors in transplant arteriosclerosis.
Kouwenhoven EA; Marquet RL; Bonthuis F; IJzermans JN; de Bruin RW
Transplant Proc; 1997 May; 29(3):1721-2. PubMed ID: 9142246
[No Abstract] [Full Text] [Related]
15. Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506.
Walgenbach KJ; Kalff JC; Sonmez-Alpan E; Hirner A; Bauer AJ
Transplant Proc; 1998 Sep; 30(6):2587. PubMed ID: 9745501
[No Abstract] [Full Text] [Related]
16. Alloimmune response may be involved in neointimal hyperplasia in cryopreserved aortic allografts.
Osako M; Otani H; Yamamura T; Nakao Y; Hattori R; Omiya H; Fujii H; Tanaka K; Imamura H
Transplant Proc; 2001 Jun; 33(4):2566-70. PubMed ID: 11406250
[No Abstract] [Full Text] [Related]
17. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
[No Abstract] [Full Text] [Related]
18. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
Stoltenberg R; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
[No Abstract] [Full Text] [Related]
19. Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model.
Teranishi K; Poston RS; Tsao PS; Asagami T; Cooke JP; Reitz BA; Robbins RC
Transplant Proc; 1998 Jun; 30(4):1012-3. PubMed ID: 9636409
[No Abstract] [Full Text] [Related]
20. A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge.
Lorber MI; Wilson JH; Harding MW; Gromkowski S; Marks WH
Transplantation; 1991 Jul; 52(1):167-70. PubMed ID: 1713364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
